The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
Jul. 15, 2022
Applicant:
Boehringer Ingelheim Vetmedica Gmbh, Duluth, GA (US);
Inventors:
Michel Bublot, Chaponost, FR;
Teshome Mebatsion, Watkinsville, GA (US);
Joyce Pritchard, Gainesville, GA (US);
Perry Linz, Jefferson, GA (US);
Aemro Kassa, Watkinsville, GA (US);
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., Duluth, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/869 (2006.01); A61K 39/12 (2006.01); A61K 39/155 (2006.01); A61K 39/245 (2006.01); A61K 39/295 (2006.01); C07K 14/03 (2006.01); C07K 14/08 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/869 (2013.01); A61K 39/12 (2013.01); A61K 39/155 (2013.01); A61K 39/245 (2013.01); A61K 39/295 (2013.01); C07K 14/03 (2013.01); C07K 14/08 (2013.01); C12N 7/00 (2013.01); C12N 2710/16311 (2013.01); C12N 2710/16334 (2013.01); C12N 2710/16343 (2013.01); C12N 2710/16363 (2013.01); C12N 2720/10034 (2013.01); C12N 2760/16163 (2013.01); C12N 2760/18134 (2013.01); C12N 2760/18163 (2013.01); C12N 2830/20 (2013.01); C12N 2830/50 (2013.01); C12N 2840/203 (2013.01);
Abstract
The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.